Balchem Corporation

Company Profile

Balchem Corporation had its IPO on 1986-06-03 under the ticker symbol BCPC.

The company operates in the LIFE SCIENCES sector and CHEMICALS & ALLIED PRODUCTS industry. Balchem Corporation has a staff strength of 0 employees.

Stock update

Shares of Balchem Corporation opened at $139.69 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $134.88 - $140.99, and closed at $134.88.

This is a -3.17% slip from the previous day's closing price.

A total volume of 126,563 shares were traded at the close of the day’s session.

In the last one week, shares of Balchem Corporation have slipped by -0.09%.

Balchem Corporation's Key Ratios

Balchem Corporation has a market cap of $4.332 billion, indicating a price to book ratio of 4.994 and a price to sales ratio of 4.942.

In the last 12-months Balchem Corporation’s revenue was $0.877 billion with a gross profit of $0.243 billion and an EBITDA of $0.193 billion. The EBITDA ratio measures Balchem Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Balchem Corporation’s operating margin was 16.6% while its return on assets stood at 6.52% with a return of equity of 12.3%.

In Q2, Balchem Corporation’s quarterly earnings growth was a positive 31.4% while revenue growth was a positive 17%.

Balchem Corporation’s PE and PEG Ratio

Forward PE

34.13

Trailing PE

40.38

PEG

8.29

Its diluted EPS in the last 12-months stands at $3.34 per share while it has a forward price to earnings multiple of 34.13 and a PEG multiple of 8.29. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Balchem Corporation’s profitability.

Balchem Corporation stock is trading at a EV to sales ratio of 5.56 and a EV to EBITDA ratio of 25.24. Its price to sales ratio in the trailing 12-months stood at 4.942.

Balchem Corporation stock pays annual dividends of $0.64 per share, indicating a yield of 0.46% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Balchem Corporation ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Balchem Corporation ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Balchem Corporation’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Balchem Corporation's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Balchem Corporation paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$134.88

52-Week High

$173.8

52-Week Low

$110.15

Analyst Target Price

$164.33

Balchem Corporation stock is currently trading at $134.88 per share. It touched a 52-week high of $173.8 and a 52-week low of $173.8. Analysts tracking the stock have a 12-month average target price of $164.33.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.